TY - JOUR
T1 - The Unique Role of Fluorodeoxyglucose-PET in Radioembolization
AU - Bastiaannet, Remco
AU - Lodge, Martin A.
AU - de Jong, Hugo W.A.M.
AU - Lam, Marnix G.E.H.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/10
Y1 - 2019/10
N2 - Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.
AB - Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.
KW - Dose–response
KW - FDG-PET
KW - Metabolic response assessment
KW - Radioembolization
UR - http://www.scopus.com/inward/record.url?scp=85069930531&partnerID=8YFLogxK
U2 - 10.1016/j.cpet.2019.06.002
DO - 10.1016/j.cpet.2019.06.002
M3 - Review article
C2 - 31472742
AN - SCOPUS:85069930531
SN - 1556-8598
VL - 14
SP - 447
EP - 457
JO - PET Clinics
JF - PET Clinics
IS - 4
ER -